• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Mar 2005; 64(Suppl 2): ii18–ii23.
PMCID: PMC1766861

Psoriasis: epidemiology, clinical features, and quality of life


Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. It can have a significant negative impact on the physical, emotional, and, psychosocial wellbeing of affected patients. Psoriasis is found worldwide but the prevalence varies among different ethnic groups. It has a strong genetic component but environmental factors such as infections can play an important role in the presentation of disease. There are several clinical cutaneous manifestations of psoriasis but most commonly the disease presents as chronic, symmetrical, erythematous, scaling papules and plaques. The epidemiology, clinical features, and impact on quality of life of psoriasis are reviewed.

Full Text

The Full Text of this article is available as a PDF (234K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Green AC. Australian Aborigines and psoriasis. Australas J Dermatol. 1984 Apr;25(1):18–24. [PubMed]
  • Burch PR, Rowell NR. Mode of inheritance in psoriasis. Arch Dermatol. 1981 May;117(5):251–252. [PubMed]
  • Smith AE, Kassab JY, Rowland Payne CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology. 1993;186(3):181–186. [PubMed]
  • Ferrándiz Carlos, Pujol Ramon M, García-Patos Vicente, Bordas Xavier, Smandía Joan A. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002 Jun;46(6):867–873. [PubMed]
  • Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985 Sep;13(3):450–456. [PubMed]
  • Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148(1):1–18. [PubMed]
  • Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet. 1997 May;6(5):813–820. [PubMed]
  • Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees JJ, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet. 1997 Aug;6(8):1349–1356. [PubMed]
  • Capon F, Semprini S, Dallapiccola B, Novelli G. Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21. Am J Hum Genet. 1999 Dec;65(6):1798–1800. [PMC free article] [PubMed]
  • Enlund F, Samuelsson L, Enerbäck C, Inerot A, Wahlström J, Yhr M, Torinsson A, Martinsson T, Swanbeck G. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q. Hum Hered. 1999 Jan;49(1):2–8. [PubMed]
  • Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B, Jones AB, Ameen M, Balendran N, Powis SH, et al. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet. 2001 Jan;38(1):7–13. [PMC free article] [PubMed]
  • Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000 Jun;66(6):1833–1844. [PMC free article] [PubMed]
  • Capon F, Novelli G, Semprini S, Clementi M, Nudo M, Vultaggio P, Mazzanti C, Gobello T, Botta A, Fabrizi G, et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol. 1999 Jan;112(1):32–35. [PubMed]
  • Enlund F, Samuelsson L, Enerbäck C, Inerot A, Wahlström J, Yhr M, Torinsson A, Riley J, Swanbeck G, Martinsson T. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur J Hum Genet. 1999 Oct-Nov;7(7):783–790. [PubMed]
  • Matthews D, Fry L, Powles A, Weber J, McCarthy M, Fisher E, Davies K, Williamson R. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet. 1996 Oct;14(2):231–233. [PubMed]
  • Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science. 1994 May 20;264(5162):1141–1145. [PubMed]
  • Lee YA, Rüschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A, Nürnberg G, Ständer M, Wienker TF, Reis A, Traupe H. Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet. 2000 Oct;67(4):1020–1024. [PMC free article] [PubMed]
  • Martin BA, Chalmers RJ, Telfer NR. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol. 1996 Jun;132(6):717–718. [PubMed]
  • Asumalahti Kati, Ameen Mahreen, Suomela Sari, Hagforsen Eva, Michaëlsson Gerd, Evans Julie, Munro Margo, Veal Colin, Allen Michael, Leman Joyce, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003 Apr;120(4):627–632. [PubMed]
  • O'Doherty CJ, MacIntyre C. Palmoplantar pustulosis and smoking. Br Med J (Clin Res Ed) 1985 Sep 28;291(6499):861–864. [PMC free article] [PubMed]
  • Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281–285. [PubMed]
  • Finlay AY, Kelly SE. Psoriasis--an index of disability. Clin Exp Dermatol. 1987 Jan;12(1):8–11. [PubMed]
  • Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995 Feb;132(2):236–244. [PubMed]
  • Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol. 1989 Jan;20(1):53–63. [PubMed]
  • Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Suicidal ideation in psoriasis. Int J Dermatol. 1993 Mar;32(3):188–190. [PubMed]
  • Savin JA. Patients' beliefs about psoriasis. Trans St Johns Hosp Dermatol Soc. 1970;56(2):139–142. [PubMed]
  • Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001 Jan;50(1):11–15. [PubMed]
  • Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res. 1997 May;42(5):467–475. [PubMed]
  • Kirby B, Fortune DG, Bhushan M, Chalmers RJ, Griffiths CE. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol. 2000 Apr;142(4):728–732. [PubMed]
  • Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol. 2001 Jul;45(1):72–76. [PubMed]
  • Finlay AY, Kelly SE. Psoriasis--an index of disability. Clin Exp Dermatol. 1987 Jan;12(1):8–11. [PubMed]
  • Fortune Donal G, Richards Helen L, Kirby Brian, McElhone Kathleen, Markham Trevor, Rogers Sarah, Main Chris J, Griffiths Christopher E M. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol. 2003 Jun;139(6):752–756. [PubMed]
  • Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CEM. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002 Mar;146(3):458–465. [PubMed]
  • Seville RH. Psoriasis and stress. Br J Dermatol. 1977 Sep;97(3):297–302. [PubMed]
  • Fortune DG, Richards HL, Main CJ, Griffiths CE. What patients with psoriasis believe about their condition. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):196–201. [PubMed]
  • Jorgensen C, Bressot N, Bologna C, Sany J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol. 1995 Oct;22(10):1829–1833. [PubMed]
  • De Korte John, Mombers Femke M C, Sprangers Mirjam A G, Bos Jan D. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol. 2002 Sep;138(9):1221–1227. [PubMed]
  • de Korte John, Sprangers Mirjam A, Mombers Femke M, Bos Jan D. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004 Mar;9(2):140–147. [PubMed]
  • Sampogna Francesca, Sera Francesco, Abeni Damiano. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol. 2004 Mar;122(3):602–607. [PubMed]
  • Lewis Victoria, Finlay Andrew Y. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004 Mar;9(2):169–180. [PubMed]
  • Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995 Feb;132(2):236–244. [PubMed]
  • McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004 Feb;63(2):162–169. [PMC free article] [PubMed]
  • McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CEM, Van Assche D. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003 Aug;149(2):323–331. [PubMed]
  • Chen Suephy C, Bayoumi Ahmed M, Soon Seaver L, Aftergut Kent, Cruz Ponciano, Sexton Shenara A, McCall Calvin O, Goldstein Mary K. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004 Mar;9(2):160–168. [PubMed]
  • Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol. 2001 May;144(5):967–972. [PubMed]
  • Pallis AG, Mouzas IA, Vlachonikolis IG. The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis. 2004 May;10(3):261–269. [PubMed]
  • Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JW. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994 Feb;106(2):287–296. [PubMed]
  • Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979 Oct;77(4 Pt 2):843–846. [PubMed]
  • Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R, Jr, Paulus H, Strand V, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995 Jun;38(6):727–735. [PubMed]
  • Paulus HE, Bulpitt KJ, Ramos B, Park G, Wong WK. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis. Arthritis Rheum. 2000 Dec;43(12):2743–2750. [PubMed]

Figures and Tables

Figure 1
 Symmetrical distribution of psoriatic lesions on the back and elbows.
Figure 2
 Nummular (coin-sized) lesions of psoriasis.
Figure 3
 Palmoplantar pustulosis.
Figure 4
 Nail changes in psoriasis. Reproduced with permission.
Figure 5
 Nail plates in a patient with psoriasis. They are thickened, dystrophic, and show orange-yellow areas (oil spots).

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...